Real‐world data on the efficacy and safety of immune‐checkpoint inhibitors in elderly patients with non‐small cell lung cancer

PURPOSE: Immune‐checkpoint inhibitors (ICIs) are effective against advanced non‐small cell lung cancer (NSCLC). However, whether the efficacy and safety of ICI treatment in elderly patients are similar to those in younger patients is unclear. This study was designed to address this question. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Morinaga, Daisuke, Asahina, Hajime, Ito, Shotaro, Honjo, Osamu, Tanaka, Hisashi, Honda, Ryoichi, Yokouchi, Hiroshi, Nakamura, Keiichi, Takamura, Kei, Hommura, Fumihiro, Kawai, Yasutaka, Ito, Kenichiro, Sukoh, Noriaki, Yokoo, Keiki, Morita, Ryo, Harada, Toshiyuki, Takashina, Taichi, Goda, Tomohiro, Dosaka‐Akita, Hirotoshi, Isobe, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242309/
https://www.ncbi.nlm.nih.gov/pubmed/36999734
http://dx.doi.org/10.1002/cam4.5889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242309/
https://www.ncbi.nlm.nih.gov/pubmed/36999734
http://dx.doi.org/10.1002/cam4.5889

Ejemplares similares